iVeena Delivery Systems, Inc. is a privately held, clinical stage ophthalmology company developing disease-modifying pharmacologic innovations for refractive diseases. iVeena has licensed its lead asset to Glaukos Corporation, IVMED-80, an Orphan Drug Designated eye drop for keratoconus. iVeena is developing IVMED-85, a first-in-class, investigational eyedrop formulation for pediatric myopia.
The company’s lead programs comprise of novel proprietary products; IVMED-80 for keratoconus and IVMED-85 for myopia.
Company Details
- Employees
- 8
- Address
- Salt Lake City, Ut 84108, Us
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- iveenamed.com
- Keywords
- Seattle.
- HQ
- Salt Lake City, UT
Iveena Questions
Iveena's website is iveenamed.com
Iveena's LinkedIn profile is https://www.linkedin.com/company/iveena
Iveena has
8 employees.
View email and phone details for 8
employees at Iveena.
Iveena's industry is
Pharmaceutical Manufacturing
Iveena's top competitors are
Othership,
Basepower,
Arena Bioworks,
Big Bold Health,
Asclepix Therapeutics,
Ria Health,
Hypori,
Bounce,
Read Ai,
Socket.
Iveena's categories are Pharmaceutical Manufacturing
